Convalescent Plasma Therapy Market Report 2026
Convalescent Plasma Therapy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Convalescent Plasma Therapy Market Report 2026

Global Outlook – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment ), By End-Users (Hospitals And Clinics, Laboratories And Research institutes ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Convalescent Plasma Therapy Market Overview

• Convalescent Plasma Therapy market size has reached to $0.06 billion in 2025

• Expected to grow to $0.11 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%

• Growth Driver: Rising Prevalence Of Infectious Diseases Driving The Market Growth Due To Increased Infections

• Market Trend: Kamada Ltd. Advances Hyperimmune Globulin Therapy with CYTOGAM for High-Risk Transplant Patients

North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Convalescent Plasma Therapy Market?

Convalescent plasma is plasma that has been collected from people who have recovered or are convalescing and contains antibodies against the infection-causing microorganism. It is used for the treatment of patients infected by the respective pathogen.

The main antibody types of convalescent plasma therapy are IgM, IgG, and IgA. Immunoglobulin A (IgA) is an antibody that is essential for mucous membrane immunological activity. The different applications include prophylaxis, and treatment and are used in various sectors such as hospitals and clinics, laboratories, and research institutes.

Convalescent Plasma Therapy Market Global Report 2026 Market Report bar graph

What Is The Convalescent Plasma Therapy Market Size and Share 2026?

The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from $0.06 billion in 2025 to $0.06 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to urgent pandemic treatment demand, lack of targeted therapeutics, availability of recovered donors, emergency use authorizations, hospital-based plasma transfusion.

What Is The Convalescent Plasma Therapy Market Growth Forecast?

The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.11 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to preparedness for future outbreaks, advancements in antibody testing, improved plasma storage technologies, expansion of transfusion services, research into immune therapies. Major trends in the forecast period include increased use in emerging infectious disease treatment, growing focus on high-titer antibody plasma, expansion of plasma collection infrastructure, improved donor screening and selection, integration with hospital-based critical care.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Convalescent Plasma Therapy Market Segmentation

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma

What Are The Drivers Of The Convalescent Plasma Therapy Market?

The rising prevalence of infectious diseases is expected to propel the growth of the convalescent plasma therapy market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted from one person to another or through contaminated environments. The prevalence of infectious diseases is rising due to increased urbanization and global travel, which lead to closer human contact and faster spread of pathogens. Convalescent plasma therapy helps combat infectious diseases by using plasma from recovered patients, which contains antibodies that can neutralize pathogens and provide passive immunity to those currently infected, thereby supporting the body’s defense against the disease. For instance, in October 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from 7.5 million in 2022, representing the highest number recorded since global TB surveillance started. Therefore, the rising prevalence of infectious diseases is driving the growth of the Convalescent Plasma Therapy industry.

The increase in the number of hospitals is expected to propel the growth of the convalescent plasma therapy market going forward. A hospital is a specialized medical facility designed to provide a wide range of healthcare services, including diagnosis, treatment, and care for patients with various medical conditions and illnesses. Increased hospital numbers often correlate with improved healthcare infrastructure. This, in turn, translates to better facilities for collecting, processing and administering convalescent plasma, thereby raising the quality of care. For instance, in April 2025, according to the Hellenic Statistical Authority, a Greece-based national government statistics agency, the number of hospitals in the country increased from 265 units in 2022 to 266 units in 2023, reflecting a 0.4% rise. Therefore, the increase in the number of hospitals is driving the growth of the convalescent plasma therapy industry.

Key Players In The Global Convalescent Plasma Therapy Market

Major companies operating in the convalescent plasma therapy market are Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc.

Global Convalescent Plasma Therapy Market Trends and Insights

Major companies operating in the convalescent plasma therapy market are focusing on developing innovative solutions, such as hyperimmune globulin therapies, to enhance treatment efficacy and address challenges associated with standard plasma therapies. Hyperimmune Globulin Therapies refer to treatments that utilize plasma with a high concentration of specific antibodies, derived from individuals who have recovered from an infection, to provide targeted and potent immune support for patients. For instance, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant advancements regarding its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]), now commercially available in the U.S. following FDA approval for its manufacturing facility in Israel. At IDWeek 2023, new clinical data demonstrated a five-year survival benefit for high-risk CMV mismatch lung transplant patients receiving CYTOGAM. Additionally, Kamada has formed its first Scientific Advisory Board to enhance U.S. clinical programs for the product.

Need data on a specific region in this market?

Regional Outlook

North America was the largest region in the convalescent plasma therapy market in 2025. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Convalescent Plasma Therapy Market?

The convalescent plasma therapy market includes revenue earned by IgD and IgE. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Convalescent Plasma Therapy Market Report 2026?

The convalescent plasma therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the convalescent plasma therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Convalescent Plasma Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.06 billion
Revenue Forecast In 2035 $0.11 billion
Growth Rate CAGR of 13.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Antibody type, Application, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Convalescent Plasma Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Convalescent Plasma Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Convalescent Plasma Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Convalescent Plasma Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increased Use In Emerging Infectious Disease Treatment

4.2.2 Growing Focus On High-Titer Antibody Plasma

4.2.3 Expansion Of Plasma Collection Infrastructure

4.2.4 Improved Donor Screening And Selection

4.2.5 Integration With Hospital-Based Critical Care

5. Convalescent Plasma Therapy Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Blood Banks

5.3 Research Institutes

5.4 Transfusion Centers

5.5 Diagnostic Laboratories

6. Convalescent Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Convalescent Plasma Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Convalescent Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Convalescent Plasma Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Convalescent Plasma Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Convalescent Plasma Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Convalescent Plasma Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Convalescent Plasma Therapy Market Segmentation

9.1. Global Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IgM, IgG, IgA

9.2. Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prophylaxis, Treatment

9.3. Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Laboratories And Research institutes

9.4. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Stage Infection Plasma, Acute Phase Plasma

9.5. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

High Titer IgG Plasma, Standard IgG Plasma

9.6. Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Plasma Rich In IgA, Specific IgA Antibody Plasma

10. Convalescent Plasma Therapy Market Regional And Country Analysis

10.1. Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Convalescent Plasma Therapy Market

11.1. Asia-Pacific Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Convalescent Plasma Therapy Market

12.1. China Convalescent Plasma Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Convalescent Plasma Therapy Market

13.1. India Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Convalescent Plasma Therapy Market

14.1. Japan Convalescent Plasma Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Convalescent Plasma Therapy Market

15.1. Australia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Convalescent Plasma Therapy Market

16.1. Indonesia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Convalescent Plasma Therapy Market

17.1. South Korea Convalescent Plasma Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Convalescent Plasma Therapy Market

18.1. Taiwan Convalescent Plasma Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Convalescent Plasma Therapy Market

19.1. South East Asia Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Convalescent Plasma Therapy Market

20.1. Western Europe Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Convalescent Plasma Therapy Market

21.1. UK Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Convalescent Plasma Therapy Market

22.1. Germany Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Convalescent Plasma Therapy Market

23.1. France Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Convalescent Plasma Therapy Market

24.1. Italy Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Convalescent Plasma Therapy Market

25.1. Spain Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Convalescent Plasma Therapy Market

26.1. Eastern Europe Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Convalescent Plasma Therapy Market

27.1. Russia Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Convalescent Plasma Therapy Market

28.1. North America Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Convalescent Plasma Therapy Market

29.1. USA Convalescent Plasma Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Convalescent Plasma Therapy Market

30.1. Canada Convalescent Plasma Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Convalescent Plasma Therapy Market

31.1. South America Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Convalescent Plasma Therapy Market

32.1. Brazil Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Convalescent Plasma Therapy Market

33.1. Middle East Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Convalescent Plasma Therapy Market

34.1. Africa Convalescent Plasma Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Convalescent Plasma Therapy Market, Segmentation By Antibody type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Convalescent Plasma Therapy Market Regulatory and Investment Landscape

36. Convalescent Plasma Therapy Market Competitive Landscape And Company Profiles

36.1. Convalescent Plasma Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Convalescent Plasma Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Convalescent Plasma Therapy Market Company Profiles

36.3.1. Bio Farma Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Biotest AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. BPL Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. LFB SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis

37. Convalescent Plasma Therapy Market Other Major And Innovative Companies

CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc.

38. Global Convalescent Plasma Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Convalescent Plasma Therapy Market

40. Convalescent Plasma Therapy Market High Potential Countries, Segments and Strategies

40.1 Convalescent Plasma Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Convalescent Plasma Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Convalescent Plasma Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Convalescent Plasma Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Convalescent Plasma Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Convalescent Plasma Therapy Market, Supply Chain Analysis
  • Table 4: Global Convalescent Plasma Therapy Market, Major Raw Material Providers
  • Table 5: Global Convalescent Plasma Therapy Market, Major Resource Providers
  • Table 6: Global Convalescent Plasma Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Convalescent Plasma Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Convalescent Plasma Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Convalescent Plasma Therapy Market, Major Trends
  • Table 10: Global Convalescent Plasma Therapy Market, Major End Users
  • Table 11: Global Convalescent Plasma Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Convalescent Plasma Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Convalescent Plasma Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Convalescent Plasma Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Convalescent Plasma Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Convalescent Plasma Therapy Market - Company Scoring Matrix
  • Table 97: Bio Farma Financial Performance
  • Table 98: Biotest AG Financial Performance
  • Table 99: BPL Ltd. Financial Performance
  • Table 100: LFB SA Financial Performance
  • Table 101: Octapharma AG Financial Performance
  • Table 102: Global Convalescent Plasma Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Convalescent Plasma Therapy Market, Competitive Dashboard
  • Table 104: Global Convalescent Plasma Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Convalescent Plasma Therapy Market Size Gain ($ Billion), Segmentation By Antibody type, 2025 – 2030
  • Table 106: Global, Convalescent Plasma Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 107: Global, Convalescent Plasma Therapy Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

List Of Figures

    Figure 1: Global Convalescent Plasma Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Convalescent Plasma Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Convalescent Plasma Therapy Market, Supply Chain Analysis
  • Figure 4: Global Convalescent Plasma Therapy Market, Major Raw Material Providers
  • Figure 5: Global Convalescent Plasma Therapy Market, Major Resource Providers
  • Figure 6: Global Convalescent Plasma Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Convalescent Plasma Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Convalescent Plasma Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Convalescent Plasma Therapy Market, Major Trends
  • Figure 10: Global Convalescent Plasma Therapy Market, Major End Users
  • Figure 11: Global Convalescent Plasma Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Convalescent Plasma Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Convalescent Plasma Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Convalescent Plasma Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgM, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgG, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Convalescent Plasma Therapy Market, Sub-Segmentation Of IgA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Convalescent Plasma Therapy Market, Segmentation By Antibody type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Convalescent Plasma Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Convalescent Plasma Therapy Market - Company Scoring Matrix
  • Figure 97: Bio Farma Financial Performance
  • Figure 98: Biotest AG Financial Performance
  • Figure 99: BPL Ltd. Financial Performance
  • Figure 100: LFB SA Financial Performance
  • Figure 101: Octapharma AG Financial Performance
  • Figure 102: Global Convalescent Plasma Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Convalescent Plasma Therapy Market, Competitive Dashboard
  • Figure 104: Global Convalescent Plasma Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Convalescent Plasma Therapy Market Size Gain ($ Billion), Segmentation By Antibody type, 2025 – 2030
  • Figure 106: Global, Convalescent Plasma Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 107: Global, Convalescent Plasma Therapy Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

Frequently Asked Questions

The Convalescent Plasma Therapy market was valued at $0.06 billion in 2025, increased to $0.06 billion in 2026, and is projected to reach $0.11 billion by 2030.

The global Convalescent Plasma Therapy market is expected to grow at a CAGR of 13.5% from 2026 to 2035 to reach $0.11 billion by 2035.

Some Key Players in the Convalescent Plasma Therapy market Include, Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc. .

Major trend in this market includes: Kamada Ltd. Advances Hyperimmune Globulin Therapy with CYTOGAM for High-Risk Transplant Patients. For further insights on this market. request a sample here

North America was the largest region in the convalescent plasma therapy market in 2025. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts